Rheumatoid Arthritis Completed Phase 2 Trials for Abatacept (DB01281)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00124449Study of Abatacept Versus Placebo to Assess the Prevention of Rheumatoid Arthritis (RA) in Adult Patients
NCT00162279The Study of Abatacept in Combination With EtanerceptTreatment
NCT00162266Abatacept With Methotrexate- Phase IIBTreatment
NCT00345748A Study of Abatacept in Japanese Patients With Active Rheumatoid Arthritis While Receiving MethotrexateTreatment